These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10408001)

  • 21. Long-term therapy of coronary artery disease: a vascular biology perspective.
    Mathé AJ; Clearfield MB
    J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S13-6. PubMed ID: 11191116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-effectiveness of coronary heart disease prevention].
    Wendland G; Klever-Deichert G; Lauterbach K
    Z Kardiol; 2002; 91 Suppl 2():49-60. PubMed ID: 12436765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recommendations for comprehensive risk reduction for patients with coronary heart disease, vascular diseases and diabetes. Distributed by the leadership of the German Society of Cardiology-Heart- and Vascular Research. Produced by request of the Committee of Clinical Cardiology by the Prevention Project Group].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2002; 91 Suppl 2():61-2. PubMed ID: 12436766
    [No Abstract]   [Full Text] [Related]  

  • 27. The importance of reaching lipid targets: statins and the prevention of atherosclerosis.
    Schwandt P
    Int J Clin Pract; 2003 Jun; 57(5):396-404. PubMed ID: 12846345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Statins--attaining goal values--with reference to recent studies].
    Toplak H; Schallmoser K; DeCampo A
    Wien Med Wochenschr; 1999; 149(5-6):144-5. PubMed ID: 10408006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins: established indications and controversial subgroups.
    Jukema JW; Bergheanu SC
    Heart; 2008 Dec; 94(12):1656-62. PubMed ID: 19011141
    [No Abstract]   [Full Text] [Related]  

  • 32. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Hansson L; Mancia G; Zanchetti A
    J Hypertens; 1995 Feb; 13(2):161-2. PubMed ID: 7615945
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
    Yokoyama M; Origasa H;
    Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Overview of the scoring system for cardiovascular risk estimation: role and significance of lipids].
    Savić T; Tasić I; Janković D; Bojanić V; Janković I; Miladinović-Tasić N
    Med Pregl; 2009; 62 Suppl 3():24-32. PubMed ID: 19702112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione].
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Ital Heart J Suppl; 2000 May; 1(5):692-8. PubMed ID: 10834137
    [No Abstract]   [Full Text] [Related]  

  • 39. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
    Mansia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Struijker Boudier HA; Zanchetti A; ;
    Blood Press; 2007; 16(3):135-232. PubMed ID: 17846925
    [No Abstract]   [Full Text] [Related]  

  • 40. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.